SciCombinator

Discover the most talked about and latest scientific content & concepts.

N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, L Malle, A Moreira, MD Park, L Pia, E Risson, M Saffern, B Salomé, M Esai Selvan, MP Spindler, J Tan, V van der Heide, JK Gregory, K Alexandropoulos, N Bhardwaj, BD Brown, B Greenbaum, ZH Gümüş, D Homann, A Horowitz, AO Kamphorst, MA Curotto de Lafaille, S Mehandru, M Merad and RM Samstein
Abstract
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting an unprecedented effort from the scientific community to understand the biological underpinning of COVID19 pathophysiology. In this Review, we summarize the current state of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to disease severity and death. We also discuss the rationale and clinical outcome of current therapeutic strategies as well as prospective clinical trials to prevent or treat SARS-CoV-2 infection.
Tweets*
2728
Facebook likes*
8
Reddit*
1
News coverage*
4
Blogs*
2
SC clicks
0
Concepts
-
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com